# Mannitol Dose Response Study in Cystic Fibrosis

> **NCT00251056** · PHASE2 · COMPLETED · sponsor: **Syntara** · enrollment: 48 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** mannitol
- **DRUG:** mannitol
- **DRUG:** mannitol
- **DRUG:** mannitol

## Key facts

- **NCT ID:** NCT00251056
- **Lead sponsor:** Syntara
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2008-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00251056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00251056, "Mannitol Dose Response Study in Cystic Fibrosis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00251056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*